Legalizing Medicinal Use of Psilocybin on Oregon’s November Ballot

Oregon could become the first U.S. state to LEGALIZE the (medicinal) use of a psychedelic drug.

Read more
ATAI Life Sciences acquiring Kures to develop novel therapeutics for opioid abuse

Atai Life Sciences is bolstering its R&D platform with the acquisition of New York-based Kures.

Read more
Pharmadrug Inc. Provides Update on Debt Restructuring

PharmaDrug is restructuring approximately $1 million in debt in the form of convertible debentures.

Read more
Psychedelics Investing 101: the Drug Approval Process and Drug Patents

Understanding the drug approval process that leads to drug patents and drug licensing is of critical importance for successful investing in psychedelics.

Read more
Osoyoos Provides Corporate Update on AI Pharma Acquisition

Osoyoos Cannabis provides additional details on its previously announced acquisition.

Read more
Psychedelics Investing 101: Past and Current Psychedelic Drug Clinical Studies

Psychedelic drug R&D is ramping up rapidly. The number of past and current clinical studies on these substances will surprise you.

Read more
The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research

The Psychedelics Revolution. One part changing social attitudes. One part medical necessity. One part hard economics.

Read more
Hinterland to Acquire Novamind Ventures Inc

Novamind Ventures is preparing to go public via amalgamation with unlisted public company Hinterland Metals.

Read more
IntelGenx and Cybin Corp Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film

Cybin Corp is partnering with IntelGenx Corp to produce a new delivery system for pharmaceutical-grade psilocybin.

Read more
Mydecine Adds Biotech Heavy-Hitter To Science Team

Mydecine Innovations Group has added one of the world’s pre-eminent biotech scientists to its Scientific Advisory Board.

Read more



( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )